Parexel Biotech – a patient-centric approach is in our DNA

Parexel’s Rosamund Round, Director, Patient Innovation Center and Amy McKee, Vice President, Regulatory Consulting Services sit down with Monica Theis, a breast cancer survivor and two-time clinical trial participant to discuss the challenges she faced while in a study and how virtual trials are making easier for participants.

Previous Article
Top 10 Myths About Working with the FDA for an Oncology Drug Approval
Top 10 Myths About Working with the FDA for an Oncology Drug Approval

Among biotech companies, a primary concern is how to establish a clinical strategy for scientific and comme...

Next Flipbook
Impact of Clinical Trials in Rare Disease and Oncology
Impact of Clinical Trials in Rare Disease and Oncology

×

Lets start a conversation...

First Name
Last Name
Job Title
Company Name
Country
Therapeutic Area Interest - optional
Tell us how we can help
Thank you! We'll be in touch soon.
Error - something went wrong!